Last updated 2026-08-23
- Raised Seed round led by Eli Gelman, Feb 2025
Total raised
—
Last: Undisclosed Round 2025-04
Stage
Series A
Founded
2021
Headcount
5
HQ
Tel Aviv-Yafo, Israel
Sector
Medical Devices
About
Vflow21 is an Israeli medical device company that develops innovative solutions for neurovascular diseases. The company focuses on Idiopathic Intracranial Hypertension and Tinnitus Treatment. Their primary product is VivaStent, a device for the treatment of cerebral venous insufficiency, featuring a unique delivery system designed for safe and swift trackability and deployment in tortuous cerebral venous anatomy. Vflow21 is also developing two more future products for cerebral arterial pathologies, both of which will incorporate Vflow's unique delivery system.
Funding history · 1 round · — total
1 event/round · — Total Funding
Feb 2025
★ Eli Gelman★ Sanara Capital Ventures
Headcount over time
5 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Q&A
- What is Vflow21's primary focus in medical device development?
- Vflow21 is a medical device company developing innovative solutions for neurovascular diseases, with a focus on Idiopathic Intracranial Hypertension and Tinnitus Treatment.
- What is Vflow21's main product?
- Vflow21's primary product is VivaStent, a device designed for the treatment of cerebral venous insufficiency, featuring a unique delivery system for safe and swift deployment.
- How many employees does Vflow21 currently have?
- Vflow21 has 5 employees, falling within the 1-10 employee bucket.
- Who are the co-founders of Vflow21?
- The co-founders of Vflow21 are Dr. Bilha Cahana and Dr. Anat Horev.
- Which investor participated in Vflow21's Seed round?
- Sanara Capital Ventures participated in Vflow21's Seed round in February 2025.
- What is Vflow21's current product development stage?
- Vflow21's products are currently in the R&D stage.
Team · 10
Dr. Bilha Cahana
Founder · Co-founder & Board Member
Prof. Anat Horev, MD
Founder · Co-founder & Board Member
Yossi Mazel
CEO
Boaz Harari
CTO
Eli Gelman
Chairman of the Board
Yoav Shaked
Board Member
Dr. Ajay K. Wakhloo
Board Member
Prof. Charbel Mounayer
Advisory Board Member
Prof. Tudor Jovin
Advisory Board Member
Prof. Rene Chapot
Advisory Board Member
Sectors & technology
Primary sector
Medical Devices
Technologies
Target customers
Business model
B2B
Tags
stentvascularneurovascularmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | vflow21.com/ |
|---|---|
| linkedin.com/company/96386872 |
Identifiers & details
| Legal name | Vflow 21 Ltd. |
|---|---|
| Founded | 2021 |
| Employees (exact) | 5 |
Radar intelligence
Web history (Wayback)
| Domain | vflow21.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516485901 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-10-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — shares_capital (1), people (1) |
| Registered address | שדרות דם המכבים 28 מודיעין-מכבים-רעות |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-27 | הקצאת מניות |
| 2026-06-08 | עדכון דירקטורים-הוספת דירקטור |